StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Margin Expansion (percentage points) by Year

Margin Expansion (percentage points) — Laboratory Products & Biopharma Services (%)

Thermo Fisher Scientific Margin Expansion (percentage points): 0.7% in FY2025, up 2.0 pts from a year earlier.

Latest, FY2025
0.7%
Period ended Dec 31, 2025
Change on a year earlier
+2.0 pts
-1.3% in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below

Where the FY2025 figure comes from

“LPBS: Segment income margin expansion 0.0 pts +0.9 pts +1.0 pts +0.5 pts +0.7 pts -0.1 pts +0.2 pts +1.0 pts”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMargin Expansion (percentage points) — Laboratory Products & Biopharma Services (%)Year on yearSource
FY2025Dec 31, 20250.7%+2.0 ptsQ3 2026 Reconciliation of Financial Information ↗
FY2024Dec 31, 2024-1.3%-3.1 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
FY2023Dec 31, 20231.8%–Q4 & FY2024 Reconciliation of Financial Information ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Margin Expansion (percentage points) (%), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg-margin-chg-pt-lpbs

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.